Their discovery that the etiology of the disorder is a disruption in the hypocretin receptor 2 gene (Hcrtr2) underscores the significance of hypocretins in sleep regulation and paves the way for novel therapeutic strategies for narcolepsy in humans. The gene discussed is HCRTR2; the disease is narcolepsy.